Status:

RECRUITING

Granulocyte Transfusions After Umbilical Cord Blood Transplant

Lead Sponsor:

University of Manchester

Collaborating Sponsors:

Children's Cancer and Leukaemia Group

Conditions:

Pediatric Cancer

Eligibility:

All Genders

Up to 16 years

Phase:

NA

Brief Summary

Although most children with leukaemia are cured using drugs (chemotherapy) alone, for some children additional treatments are needed. Stem cell transplant can cure children where chemotherapy and othe...

Detailed Description

Most children with acute leukaemia are cured with chemotherapy alone but a few children are either refractory to such therapy, or relapse after it has been administered. Some of these relapsed or ref...

Eligibility Criteria

Inclusion

  • Children, aged \<16 years, undergoing a first allogeneic, unrelated donor, T-cell replete, umbilical cord blood HSCT for high risk acute leukaemia.
  • Availability of at least a 6/8 allelic matched cord blood, of adequate cell dose, after allele-level matching at HLA (Human Leukocyte Antigen)-A, -B, -C, and -DRB1
  • Informed consent by parent or guardian. Age appropriate Assent will also be collected in those Children age 16 and under.

Exclusion

  • Patients participating in other HSCT clinical trial
  • The transplant not indicated according to National Health Service England (NHSE) and British Society of Bone Marrow Transplant (BSBMT) Paediatric Transplant Group.
  • Pooled Granulocyte Transfusion contraindicated for any reason
  • Previous T cell replete unrelated donor cord blood transplant
  • Patients with a previous history of sensitivity to granulocyte transfusion will be excluded from the study

Key Trial Info

Start Date :

September 14 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05425043

Start Date

September 14 2021

End Date

June 1 2026

Last Update

October 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Manchester Childrens Hospital, MFT

Manchester, United Kingdom, M13 9WL